Creon and Breastfeeding
No research has been done to determine whether Creon (pancrelipase) would pass through breast milk in women. However, the drug has been shown to be safe for use in babies, which indicates it may be safe for a woman to take Creon while breastfeeding. In many cases, the benefits the drug presents exceed the potential risks to a nursing infant.
Creon® (pancrelipase) is a prescription medication approved for the treatment of pancreatic enzyme deficiencies. It is currently unknown whether Creon passes through breast milk.
Creon has not been studied in any breastfeeding women or animals, so it is unknown if it passes through breast milk. However, keep in mind that the drug is approved for use in babies, which means it has been shown to be safe for use in infants. This suggests that it would probably be safe for use during breastfeeding.
Breastfeeding is a time of increased nutritional need for mothers, and it would not be a good time to leave a pancreatic enzyme deficiency untreated due to the risk of malnutrition. In many cases, the benefits for a breastfeeding woman to take Creon would likely exceed the potential risks to the nursing child.
You should discuss breastfeeding and Creon use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.